CuraScientific Corp.
CSTF
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | 4,804.44% | -- | -100.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 4,804.44% | -- | -100.00% | -- |
| Cost of Revenue | 430.53% | 220.82% | -5.24% | -1.02% | 1,823.08% |
| Gross Profit | -277.00% | 63.29% | -12.95% | -4.00% | -1,339.67% |
| SG&A Expenses | -31.60% | 168.94% | -67.59% | 47.07% | 84.35% |
| Depreciation & Amortization | 13.95% | 11.90% | 8.57% | 43.33% | 53.57% |
| Other Operating Expenses | -- | -- | -- | 0.00% | -- |
| Total Operating Expenses | 81.46% | 182.61% | -51.12% | 30.99% | 49.76% |
| Operating Income | -44.01% | -103.61% | 49.02% | -39.19% | -57.42% |
| Income Before Tax | -3,045.13% | 5,304.60% | 95.26% | -70.95% | 112.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3,045.13% | 5,304.60% | 95.26% | -70.95% | 112.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,045.13% | 5,304.60% | 95.26% | -70.95% | 112.07% |
| EBIT | -44.01% | -103.61% | 49.02% | -39.19% | -57.42% |
| EBITDA | 55.42% | -112.79% | 66.31% | -57.92% | -92.84% |
| EPS Basic | -125.00% | 104.03% | 98.77% | 83.63% | 100.64% |
| Normalized Basic EPS | 99.41% | 44.79% | 103.84% | 79.91% | 91.61% |
| EPS Diluted | -125.00% | 51.91% | 98.77% | 83.63% | 100.64% |
| Normalized Diluted EPS | 99.41% | 7.75% | 103.84% | 79.91% | 91.61% |
| Average Basic Shares Outstanding | 11,735.28% | 2,548.15% | 283.97% | 944.33% | 1,795.46% |
| Average Diluted Shares Outstanding | 11,735.28% | 3,459.64% | 283.97% | 944.33% | 1,795.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
